您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报(医学版) ›› 2012, Vol. 50 ›› Issue (5): 25-.

• 论文 • 上一篇    下一篇

利用重建祖先基因方法研究连续诱导培养大肠杆菌对恩诺沙星抗药性突变的规律

魏甜甜1,2,白华2,李靖冉1,胡明2,齐静2,袁首道3,张乐萃1,刘玉庆1,2   

  1. 1.青岛农业大学动物科技学院预防兽医学实验室, 山东 青岛 266109;
    2.山东省农业科学院畜牧兽医研究所, 山东省畜禽疫病防治与繁育重点实验室, 济南 250100;
    3.山东大学医学院癌症研究中心, 济南 250012
  • 收稿日期:2011-12-15 出版日期:2012-05-10 发布日期:2012-05-10
  • 通讯作者: 刘玉庆(1969- ),男,研究员,博士,主要从事细菌性传染病防治与细菌抗药性的研究。 E-mail:15253178966@163.com
  • 作者简介:魏甜甜(1986- ), 女,硕士研究生,主要从事细菌抗药性的研究
  • 基金资助:

    国家自然科学基金资助项目(81171621),公益性行业(农业)科研专项基金资助项目(200903055、201203040),山东省自然科学基金资助项目(ZR2010HQ047),山东省科技发展计划基金资助项目(2010GNC10952)。

The law of the resistant mutation of Escherichia coli strains continuously
induced with Enrofloxacin by ancestral gene reconstruction

WEI Tian-tian1,2, BAI Hua2, LI Jing-ran1, HU Ming2, QI Jing2,
YUAN Shou-dao3, ZHANG Le-cui1,  LIU Yu-qing2   

  1. 1. College of Animal Science and Technology, Qingdao Agricultural University, Qingdao 266109, Shandong, China;
    2. Institute of Animal Science and Veterinary Medicine, Shandong Key Laboratory of Animal Disease Control and Breeding,
    Shandong Academy of Agricultural Science, Jinan 250100, China;
    3. Cancer research center, Shandong University, Jinan 250012, China
  • Received:2011-12-15 Online:2012-05-10 Published:2012-05-10

摘要:

目的   研究大肠杆菌对氟喹诺酮抗药性突变的规律及基因型与表型的对应关系。方法   以质控菌株Escherichia coli ATCC 25922为初始菌株,恩诺沙星浓度由0.03125μg/mL增加到128μg/mL,分步诱导得到13株稳定的抗药性菌株,检测氟喹诺酮靶酶基因gyrA、gyrB和parC、parE的序列及其突变位点,检测恩诺沙星的最低抑菌浓度(MIC)及抑制外排泵后MIC,分析抗药性表型与基因型、蛋白结构、外排泵及生化特性的关系。结果   低浓度氟喹诺酮可诱导GyrA 的Ser83-Leu和 ParC的 Glu84Lys单一位点突变,致低水平抗药性,而Ser83-Leu逐步与Asp87-Gly、Glu84-Lys组合,导致氟喹诺酮突变决定区突变位点氨基酸的极性、空间位阻变化,影响靶蛋白与DNA和恩诺沙星的结合,可致高水平抗药性。外排泵与基因突变共同作用,使细菌耐受逐步升高药物浓度,MIC基本平行高出培养浓度1倍。结论   增加恩诺沙星的使用剂量,能诱导高抗菌株产生,恩诺沙星抗药性表型与基因型具有对应关系和规律性变化。

关键词: 大肠杆菌;抗感染药,氟喹诺酮;连续传代;点突变

Abstract:

Objective   To study the mutation law of fluoroquinolone resistance of E.coli, and the correspondence between genotype and phenotype. Methods   The quality control strain Escherichia coli ATCC 25922 was used as the initial strain to continuously induce with increasing concentrations of enrofloxacin from 0.03125μg/mL to 128μg/mL, and 13 stable enrofloxacin-resistant strains were obtained. The mutation sites were detected by complete sequencing fluoroquinolone target gene gyrA, gyrB, parC, and parE. while the corresponding MICs and MIC by efflux pump inhibition of each strain were measured. Then the relationships between resistance phenotypes and the genotypes, protein structures, biochemical properties and efflux pump activities were analyzed.  Results   Low concentrations of fluoroquinolone did not induce high resistance mutations. A single locus of mutation Ser83Leu in GyrA, and even combined with mutation Glu84Lys in ParC could cause low-level resistance. However, Ser83-Leu gradually combined with Asp87-Gly and Glu84-Lys mutations resulting in the changes of polar and steric effects of mutation amino acids in the “Quinolones resistance determining region”, which induced high resistance mutations by precluding the combination of enrofloxacin, target proteins and DNA. In addition, Efflux pumps combined with gene mutations led to bacterial tolerance to the gradually increasing drug concentrations. MIC had about twice the inducing drug concentrations. Conclusion   An increasing dose of fluoroquinolone can induce high resistance, and there are regular corresponding relationships between phenotypes and genotypes of enrofloxacin resistance.

Key words: Escherichia coli; Antiinfective agents, fluoroquinolone; Serial passage; Point mutation

中图分类号: 

  • R743.2
[1] 张欣1,牟洁2,于文成1,刘畅畅3,刘园园1. 肺通口服液治疗鼠肺间质纤维化对弹性蛋白酶的影响[J]. 山东大学学报(医学版), 2012, 50(1): 24-.
[2] 李海军,肖伟. 肺腺癌患者外周血Th17细胞比例变化及临床意义[J]. 山东大学学报(医学版), 2011, 49(8): 108-112.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!